These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 26534901)

  • 1. Pancreatic Cancer Metabolism: Breaking It Down to Build It Back Up.
    Perera RM; Bardeesy N
    Cancer Discov; 2015 Dec; 5(12):1247-61. PubMed ID: 26534901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism.
    Perera RM; Stoykova S; Nicolay BN; Ross KN; Fitamant J; Boukhali M; Lengrand J; Deshpande V; Selig MK; Ferrone CR; Settleman J; Stephanopoulos G; Dyson NJ; Zoncu R; Ramaswamy S; Haas W; Bardeesy N
    Nature; 2015 Aug; 524(7565):361-5. PubMed ID: 26168401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism addiction in pancreatic cancer.
    Blum R; Kloog Y
    Cell Death Dis; 2014 Feb; 5(2):e1065. PubMed ID: 24556680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma.
    García-Reyes B; Kretz AL; Ruff JP; von Karstedt S; Hillenbrand A; Knippschild U; Henne-Bruns D; Lemke J
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30340359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unraveling the complexity of autophagy: Potential therapeutic applications in Pancreatic Ductal Adenocarcinoma.
    Gómez VE; Giovannetti E; Peters GJ
    Semin Cancer Biol; 2015 Dec; 35():11-9. PubMed ID: 26408419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel targets in pancreatic cancer research.
    Kozak G; Blanco FF; Brody JR
    Semin Oncol; 2015 Feb; 42(1):177-87. PubMed ID: 25726061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts in pancreatic adenocarcinoma.
    Pan B; Liao Q; Niu Z; Zhou L; Zhao Y
    Future Oncol; 2015 Sep; 11(18):2603-10. PubMed ID: 26284509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory cytokines in human pancreatic cancer.
    Roshani R; McCarthy F; Hagemann T
    Cancer Lett; 2014 Apr; 345(2):157-63. PubMed ID: 23879960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic pancreatitis: a path to pancreatic cancer.
    Pinho AV; Chantrill L; Rooman I
    Cancer Lett; 2014 Apr; 345(2):203-9. PubMed ID: 23981573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced mitochondrial glutamine anaplerosis suppresses pancreatic cancer growth through autophagy inhibition.
    Jeong SM; Hwang S; Park K; Yang S; Seong RH
    Sci Rep; 2016 Aug; 6():30767. PubMed ID: 27477484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance.
    Biancur DE; Kimmelman AC
    Biochim Biophys Acta Rev Cancer; 2018 Aug; 1870(1):67-75. PubMed ID: 29702208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity, autophagy and the pathogenesis of liver and pancreatic cancers.
    Aghajan M; Li N; Karin M
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2(Suppl 2):10-4. PubMed ID: 22320909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VAV1: a new target in pancreatic cancer?
    Denicola G; Tuveson DA
    Cancer Biol Ther; 2005 May; 4(5):509-11. PubMed ID: 15970675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: An in depth proteomic study.
    Dalla Pozza E; Manfredi M; Brandi J; Buzzi A; Conte E; Pacchiana R; Cecconi D; Marengo E; Donadelli M
    J Cell Biochem; 2018 Mar; 119(3):2696-2707. PubMed ID: 29095525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conceptual framework for cutting the pancreatic cancer fuel supply.
    Le A; Rajeshkumar NV; Maitra A; Dang CV
    Clin Cancer Res; 2012 Aug; 18(16):4285-90. PubMed ID: 22896695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells.
    Jimbo M; Blanco FF; Huang YH; Telonis AG; Screnci BA; Cosma GL; Alexeev V; Gonye GE; Yeo CJ; Sawicki JA; Winter JM; Brody JR
    Oncotarget; 2015 Sep; 6(29):27312-31. PubMed ID: 26314962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroma and pancreatic ductal adenocarcinoma: an interaction loop.
    Luo G; Long J; Zhang B; Liu C; Xu J; Ni Q; Yu X
    Biochim Biophys Acta; 2012 Aug; 1826(1):170-8. PubMed ID: 22521638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow-derived proangiogenic cells in pancreatic cancer.
    Mizukami Y
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():23-6. PubMed ID: 22320912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autophagy: Surviving stress in pancreatic cancer.
    Alderton GK
    Nat Rev Cancer; 2015 Sep; 15(9):513. PubMed ID: 26299587
    [No Abstract]   [Full Text] [Related]  

  • 20. Hypoxia-activated prodrugs in the treatment of advanced pancreatic adenocarcinoma.
    Babiker HM; Riaz IB; Shah SR; Von Hoff DD; Borad MJ
    Anticancer Drugs; 2017 Feb; 28(2):127-132. PubMed ID: 27685167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.